Contract Awarded For Delivery Of Medicinal Products Used In Drug Programs, Chemotherapy, And Others. 1. Durvalumab - Indication Lung Cancer 2. Atezolizumab - Indication Lung Cancer 3. Entecavir 4. Lamivudine 5. Tenofovir Disoproxil 6. Glecaprevir + Pibren
TK ID 528624413
Document Type
Contract Awards
Tender Summary
Contract Awarded For Delivery Of Medicinal Products Used In Drug Programs, Chemotherapy, And Others. 1. Durvalumab - Indication Lung Cancer 2. Atezolizumab - Indication Lung Cancer 3. Entecavir 4. Lamivudine 5. Tenofovir Disoproxil 6. Glecaprevir + Pibren
Action Deadline
05 Jun 2026
Don't have an account yet?Sign up here.